January 18, 2007Journal of Internal MedicineOpen Access

Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks

View Full Paper

Ask AI

Bookmark

Why the study?

Does SSRI therapy increase the risk of bleeding in patients?

Population

Patients receiving selective serotonin reuptake inhibitors (SSRIs) for psychiatric conditions

Design

Review

Authors

MTMichelle TurnerCone Health DMD. B. MayPädagogische Hochschule Wien RAR. R. ArthurCampbell University

Discussion

Member takes

Implication

Clinicians should exercise caution when prescribing SSRIs in high-risk patients due to potential antiplatelet activity and increased bleeding risk, particularly when combined with aspirin or NSAIDs.

Structured PICO

Does SSRI therapy increase the risk of bleeding in patients?

Population

Patients receiving selective serotonin reuptake inhibitors (SSRIs) for psychiatric conditions

Intervention

Selective serotonin reuptake inhibitors (SSRIs)

Outcome

Bleeding risksafety

Clinicians should exercise caution when prescribing SSRIs in high-risk patients due to potential antiplatelet activity and increased bleeding risk, particularly when combined with aspirin or NSAIDs.

Cite This Study

Turner et al. (2007) studied this question.

synapsesocial.com/papers/6a7f98ff8a9553021dec9bea https://doi.org/10.1111/j.1365-2796.2006.01720.x

View Full Paper

Ask AI

Bookmark

Implication

Clinicians should exercise caution when prescribing SSRIs in high-risk patients due to potential antiplatelet activity and increased bleeding risk, particularly when combined with aspirin or NSAIDs.

Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider